Baillie Gifford - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 226 filers reported holding INSMED INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of INSMED INC
ValueSharesWeighting
Q1 2023$13,674
-3.2%
802
+13.4%
0.00%
Q4 2022$14,126
-5.8%
7070.0%0.00%
Q3 2022$15,000
+7.1%
7070.0%0.00%
Q2 2022$14,000
-17.6%
7070.0%0.00%
Q1 2022$17,000
-10.5%
7070.0%0.00%
Q4 2021$19,0000.0%7070.0%0.00%
Q3 2021$19,000
-13.6%
707
-10.2%
0.00%
Q2 2021$22,000
-18.5%
7870.0%0.00%
Q1 2021$27,000
+8.0%
787
+3.6%
0.00%
Q4 2020$25,0007600.00%
Other shareholders
INSMED INC shareholders Q4 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,533,883$44,590,00016.02%
Foresite Capital Management II, LLC 919,436$26,728,00012.07%
NEXTHERA CAPITAL LP 284,263$8,264,00010.03%
Palo Alto Investors LP 7,653,617$222,491,0009.28%
Asymmetry Capital Management, L.P. 154,887$4,503,0007.52%
ACUTA CAPITAL PARTNERS, LLC 370,000$10,756,0005.11%
Vivo Capital, LLC 1,170,290$34,020,0003.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 110,000$3,198,0001.18%
Islet Management, LP 350,000$10,175,0001.18%
EMERALD ADVISERS, LLC 921,527$26,789,0001.09%
View complete list of INSMED INC shareholders